Friday, December 15, 2017
 
 
Video: Page (1) of 1 - 07/31/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Jamario Bell Injures Foot Possibly Out for Season

By Clip Syndicate
Coach B "at some point on Saturday Jamario Bell did something to his foot...getting surgery today @ 2pm" "probably be out next 10-12 weeks...so losing him for majority of season" "Been working at the Hog end of our boundary"

http://eplayer.clipsyndicate.com/view/12451/7023940 Video: Jamario Bell Injures Foot Possibly Out for Season
Coach B "at some point on Saturday Jamario Bell did something to his foot...getting surgery today @ 2pm" "probably be out next 10-12 weeks...so losing him for majority of season" "Been working at the Hog end of our boundary"
http://chic.clipsyndicate.com/video/playlist/12451/7023940?cpt=8&wpid=2637 Mon, 31 Jul 2017 18:01:15 +0000 Jamario Bell Injures Foot Possibly Out for Season Coach B "at some point on Saturday Jamario Bell did something to his foot...getting surgery today @ 2pm" "probably be out next 10-12 weeks...so losing him for majority of season" "Been working at the Hog end of our boundary" http://chic.clipsyndicate.com/video/playlist/12451/7023940?cpt=8&wpid=2637 KNWA





Page: 1


Related Keywords:pl_razorback_nation_playlist
Related Sites: USDailyNews ,   HTN - Health Technology Net
Related Newsletter:
 
 
 
 
 
 
 
Seniors

Drugs
  • ApolloMed And Network Medical Management Announce Completion Of Merger And Listing On The Nasdaq Capital Market
  • Global Wireless Health Market Will Reach USD 427 Billion by 2022: Zion Market Research
  • Protein Expression Market, 2023
  • Global Protein Expression Market 2016-2023: Market is Expected to Grow from $1.4 Billion to $3.0 Billion
  • Dental Unit Market To Witness Enhanced Demand From Hospitals And Clinics, Dental Laboratories And Various Healthcare Sectors Till 2022 | Million Insights

    Cancer
  • Targovax to present at DNB healthcare conference
  • Low-Dose Radiation Can Enhance Natural Barriers to Cancer, according to the Journal of American Physicians and Surgeons
  • Kitov Announces Consensi™ as Brand Name for KIT-302
  • BioSight Announces Phase I/II Results of its Cytarabine Pro-Drug BST-236 for Treatment of Acute Leukemia
  • Gastrointestinal Stromal Tumor Market Will be Worth US$ 1.5 Billion by 2026 - Persistence Market Research
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines